Intermittent Fasting and Its Impact on Vascular Dementia
Understanding Vascular Dementia
Blocked or reduced blood flow to the brain is recognized as the second-most common cause of dementia in humans.
Research Overview
A team of Chinese scientists conducted a study using a rodent model to explore whether intermittent fasting (IF) could provide protection against cognitive impairment associated with vascular dementia.
What is Intermittent Fasting?
Intermittent fasting refers to a dietary regimen that alternates periods of normal eating with periods of abstinence. Various frameworks exist for IF, including:
– **Partial-Day Fasts**: Eating only within a specific time window each day.
– **Alternate-Day Fasting**: Eating freely one day and abstaining from food the next.
Many individuals adopt IF to teach the body to utilize food more efficiently and to burn fat when caloric intake is limited.
Potential Benefits of Intermittent Fasting
Interestingly, the mechanisms that contribute to weight loss and improved diabetic control during fasting appear to also enhance brain cell protection and resilience. Preclinical studies in rodent models indicate that long-term IF may mitigate cognitive deficits.
Methodology of the Study
A study published in May 2017 in the Journal of Nutrition examined adult rats weighing at least 200g to determine if IF could safeguard against cognitive decline due to vascular dementia. The experimental design included two groups of rats:
– Two-thirds were permitted to eat on demand.
– One-third followed an alternate-day fasting regimen.
Cognitive function was assessed through novel object recognition tests, which evaluate short-term memory, and the Morris water maze test, which measures spatial learning.
After 12 weeks, both eat-on-demand rats and all IF rats underwent surgery to close two arteries, simulating reduced blood supply to the brain and modeling vascular dementia. Following a brief recovery, cognitive function was re-evaluated, and the rats were euthanized for brain tissue analysis.
Findings of the Research
The findings revealed that intermittent fasting prevented memory impairment, reduced hippocampal neuronal apoptosis, and increased synaptic density. Additionally, brain tissue analysis indicated that IF decreased inflammation and alleviated oxidative stress, thereby lessening environmental toxicity in the hippocampi that can lead to neural death and cognitive dysfunction.
Limitations and Considerations
While these results are promising, it is essential to note that no human clinical trials have yet verified that IF, or even standard calorie restriction, enhances brain health or protects against dementia in healthy individuals. Furthermore, IF may pose risks for certain populations, including those who are underweight, diabetic, ill, or frail.
Conclusion
This research contributes to our understanding of potential dietary interventions for cognitive health, but further studies are needed to establish safety and efficacy in human subjects.
Written By: Debra A. Kellen, PhD